UCHIYAMA HOLDINGS Co.,Ltd.

TSE:6059 Stok Raporu

Piyasa değeri: JP¥5.9b

UCHIYAMA HOLDINGSLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

UCHIYAMA HOLDINGSLtd's earnings have been declining at an average annual rate of -4.5%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been declining at an average rate of 0.5% per year. UCHIYAMA HOLDINGSLtd's return on equity is 1.2%, and it has net margins of 0.5%.

Anahtar bilgiler

-4.5%

Kazanç büyüme oranı

-4.5%

EPS büyüme oranı

Healthcare Sektör Büyümesi7.9%
Gelir büyüme oranı-0.5%
Özkaynak getirisi1.2%
Net Marj0.5%
Sonraki Kazanç Güncellemesi12 Nov 2024

Yakın geçmiş performans güncellemeleri

The Strong Earnings Posted By UCHIYAMA HOLDINGSLtd (TSE:6059) Are A Good Indication Of The Strength Of The Business

May 21
The Strong Earnings Posted By UCHIYAMA HOLDINGSLtd (TSE:6059) Are A Good Indication Of The Strength Of The Business

Recent updates

Returns On Capital Signal Difficult Times Ahead For UCHIYAMA HOLDINGSLtd (TSE:6059)

Aug 07
Returns On Capital Signal Difficult Times Ahead For UCHIYAMA HOLDINGSLtd (TSE:6059)

The Strong Earnings Posted By UCHIYAMA HOLDINGSLtd (TSE:6059) Are A Good Indication Of The Strength Of The Business

May 21
The Strong Earnings Posted By UCHIYAMA HOLDINGSLtd (TSE:6059) Are A Good Indication Of The Strength Of The Business

Is UCHIYAMA HOLDINGSLtd (TSE:6059) A Risky Investment?

Mar 01
Is UCHIYAMA HOLDINGSLtd (TSE:6059) A Risky Investment?

Gelir ve Gider Dağılımı

UCHIYAMA HOLDINGSLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:6059 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2428,9721521,0020
31 Mar 2428,8422139920
31 Dec 2328,405881,0060
30 Sep 2327,934-1201,0070
30 Jun 2327,279-4661,0240
31 Mar 2326,911-4001,0290
31 Dec 2226,160-7881,0310
30 Sep 2226,755-2021,0970
30 Jun 2225,984-1751,0910
31 Mar 2224,958-6501,1110
31 Dec 2124,703-5771,1000
30 Sep 2123,556-2,4291,1110
30 Jun 2123,922-2,1581,0890
31 Mar 2123,795-2,2311,1210
31 Dec 2024,701-2,5321,1350
30 Sep 2025,417-1,0491,1220
30 Jun 2026,340-9371,1800
31 Mar 2030,29521,1820
31 Dec 1930,3981,0251,1610
30 Sep 1930,3611,3851,1890
30 Jun 1930,1731,5311,1200
31 Mar 1927,2091,1021,1570
31 Dec 1827,0351,0771,1470
30 Sep 1826,7238181,1480
30 Jun 1826,6377731,2040
31 Mar 1826,4028081,1510
31 Dec 1726,2462571,1750
30 Sep 1726,2832921,1670
30 Jun 1725,7392211,1760
31 Mar 1725,318591,1890
31 Dec 1624,8007171,2380
30 Sep 1624,3057471,1470
30 Jun 1624,1638931,1520
31 Mar 1623,8979831,1120
31 Dec 1523,8901,2641,1820
30 Sep 1523,7451,2561,1270
30 Jun 1523,5271,1751,1310
31 Mar 1523,6281,2891,0970
31 Dec 1423,2381,1621,2080
30 Sep 1422,7371,2609290
30 Jun 1422,3692,1401,0530
31 Mar 1421,7582,2171,0150
31 Dec 1321,4102,2531,0290

Kaliteli Kazançlar: 6059 has a large one-off loss of ¥373.0M impacting its last 12 months of financial results to 30th June, 2024.

Büyüyen Kar Marjı: 6059 became profitable in the past.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 6059's earnings have declined by 4.5% per year over the past 5 years.

Büyüme Hızlandırma: 6059 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Kazançlar vs. Sektör: 6059 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).

Özkaynak Getirisi

Yüksek ROE: 6059's Return on Equity (1.2%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y